Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    M12-950
Show Display Options
Rank Status Study
1 Completed A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer
Condition: Locally Advanced Rectal Cancer
Interventions: Drug: veliparib;   Drug: capecitabine;   Radiation: radiation

Study has passed its completion date and status has not been verified in more than two years.